跳到主要內容
:::

林嘉興

林口長庚醫院放射腫瘤科主治醫師

放射腫瘤科

質子治療、頭頸癌/鼻咽癌、腦瘤、淋巴瘤等、影像導航的強度調控放射治療、立體定位放射線手術

教職 :

醫師網路掛號

※直接點選進入醫師網路掛號畫面※

語言

  • 國語,英語,閩南語

現職

  • 林口長庚醫院放射腫瘤科主治醫師

學歷

  • 國立陽明交通大學 醫學系

經歷

  • 2022~ 林口長庚放射腫瘤科一般級主治醫師
  • 2021~2022 林口長庚醫院 放射腫瘤科總醫師
  • 2018~2021 林口長庚放射腫瘤科住院醫師
  • 2017~2018 臺北榮民總醫院 一般科(PGY)住院醫師
  • 2015~2016 臺北榮民總醫院 實習醫師
  • 2014~2015 美國約翰霍普金斯醫院 臨床及研究 實習醫師

學會與認證

  • Taiwan Society for Therapeutic Radiology and Oncology (TASTRO)
  • European Society for Radiotherapy and Oncology (ESTRO)
  • American Society for Radiotherapy and Oncology (ASTRO)

論文及期刊發表

  • Prognostic value of interim CT-based peritumoral and intratumoral radiomics in laryngeal and hypopharyngeal cancer patients undergoing definitive radiotherapy.
  • Prognostic significance of dynamic changes in lymphocyte-to-monocyte ratio in patients with head and neck cancer treated with radiotherapy: results from a large cohort study.
  • Efficacy of Postoperative Unilateral Neck Irradiation in Patients with Buccal Mucosa Squamous Carcinoma with Extranodal Extension: A Propensity Score Analysis.
  • Prognostic Value of Lymph Node-To-Primary Tumor Standardized Uptake Value Ratio in Esophageal Squamous Cell Carcinoma Treated with Definitive Chemoradiotherapy.
  • A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma.
  • Risk Prediction for Early Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma.
  • Human Costars Family Protein ABRACL Modulates Actin Dynamics and Cell Migration and Associates with Tumorigenic Growth.
  • Long-term outcomes of frontline intensification in primary CNS lymphoma: A real-world single-center experience.
  • Prognostic significance of the preoperative systemic immune-inflammation index in patients with oral cavity squamous cell carcinoma treated with curative surgery and adjuvant therapy.
  • Oncological Outcomes After Hippocampus-Sparing Whole-Brain Radiotherapy in Cancer Patients With Newly Diagnosed Brain Oligometastases: A Single-Arm Prospective Observational Cohort Study in Taiwan.
  • Adjuvant Chemoradiotherapy Associated with Improved Overall Survival in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy in Intensity-Modulated Radiotherapy Era.
長庚醫院智能服務 有任何問題隨時找我!